Home Medicine Turner syndrome patients with bicuspid aortic valves and renal malformations exhibit abnormal expression of X-linked inhibitor of apoptosis protein (XIAP)
Article
Licensed
Unlicensed Requires Authentication

Turner syndrome patients with bicuspid aortic valves and renal malformations exhibit abnormal expression of X-linked inhibitor of apoptosis protein (XIAP)

  • Ganesh S. Jevalikar EMAIL logo , Margaret Zacharin , Mary White , Steven W. Yau , Winnie Li , Charlotte Ijspeert , Vincenzo C. Russo , George A. Werther and Matthew A. Sabin
Published/Copyright: November 12, 2014
Journal of Pediatric Endocrinology and Metabolism
From the journal Journal of Pediatric Endocrinology and Metabolism Volume 28 Issue 11-12

Abstract

Objective: We analyzed mRNA expression of X-linked inhibitor of apoptosis protein (XIAP) in patients with Turner syndrome (TS) and examined its association with phenotypic features.

Subjects and methods: XIAP mRNA expression levels were investigated in 98 patients with TS in total RNA extracted from blood leucocytes by real time quantitative polymerase chain reaction.

Results: Levels of XIAP mRNA were significantly lower in patients with bicuspid aortic valves (BAV; n=13) than those without (log XIAP –1.17±0.3 vs. –0.94±0.2, p=0.002). Significantly higher expression of XIAP mRNA was seen in patients with a mosaic karyotype and renal malformations (log XIAP –0.79±0.3 vs. –1.0±0.3, p=0.03). No correlations were seen between XIAP and other manifestations.

Conclusion: Abnormal expression of XIAP may be an important underlying mechanism in the development of BAV and renal malformations in TS. However, abnormal XIAP mRNA expression, as determined from peripheral mononuclear cells, does not appear to explain all the somatic and visceral stigmata of TS.

Keywords: apoptosis; bicuspid aortic valves; Turner syndrome; XIAP
Corresponding author: Ganesh S. Jevalikar, Division of Endocrinology and Diabetes, Medanta Medicity Hospital, Sector 38, Gurgaon (Haryana), India 122 001, Phone: +91–124–4141414 Ext. 6518, Fax: +91–124–4834–111, E-mail:

Acknowledgments

Authors from the Murdoch Children’s Research Institute are supported by the Victorian Government Operational Infrastructure Support Program. M.A. Sabin is supported through a National Health and Medical Research Council Health Professional Training Fellowship (APP1012201).

Disclosure statement: All authors have nothing to disclose.

References

1. Stochholm K, Juul S, Juel K, Naeraa RW, Gravholt CH. Prevalence, Incidence, Diagnostic delay and Mortality in Turner syndrome. J Clin Endocrinol Metab 2006;91:3897–902.10.1210/jc.2006-0558Search in Google Scholar PubMed

2. Ferguson-Smith M. Genotype-phenotype correlations in Turner syndrome. In: Hibi I, Takano K, eds. Basic and clinical approach to Turner syndrome. Amsterdam: Elsevier Science, 1993:17–25.Search in Google Scholar

3. Sybert VP, McCauley E. Turner syndrome. N Engl J Med 2004;351:1227–38.10.1056/NEJMra030360Search in Google Scholar PubMed

4. Rao E, Weiss B, Fukami M, Rump A, Niesler B, et al. Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet 1997;16:54–63.10.1038/ng0597-54Search in Google Scholar PubMed

5. Fisher SA, Langille B, Srivastava D. Apoptosis during cardiovascular development. Circ Res 2000;87:856–64.10.1161/01.RES.87.10.856Search in Google Scholar PubMed

6. Carev D, Krnic D, Saraga M, Sapunar D, Saraga-Babic M. Role of mitotic, pro-apoptotic and anti-apoptotic factors in human kidney development. Pediatr Nephrol 2006;21:627–36.10.1007/s00467-006-0057-ySearch in Google Scholar PubMed

7. Singh RP, Carr DH. Anatomy and histology of XO human embryos and fetuses. Anat Rec 1966;155:369–83.10.1002/ar.1091550309Search in Google Scholar PubMed

8. Rajcan-Separovic E, Liston P, Lefebvre C, Korneluk RG. Assignment of human inhibitor of apoptosis protein (IAP) genes xiap, hiap-1, and hiap-2 to chromosomes Xq25 and 11q22-q23 by fluorescence in situ hybridization. Genomics 1996;37:404–6.10.1006/geno.1996.0579Search in Google Scholar PubMed

9. Russo VC, Higgins S, Werther GA, Cameron FJ. Effects of fluctuating glucose levels on neuronal cells in vitro. Neurochem Res 2012;37:1768–82.10.1007/s11064-012-0789-ySearch in Google Scholar PubMed

10. Suzuki Y, Nakabayashi Y, Nakata K, Reed JC, Takahashi R. X-linked inhibitor of apoptosis protein (XIAP) inhibits caspase-3 and -7 in distinct modes. J Biol Chem 2001;276:27058–63.10.1074/jbc.M102415200Search in Google Scholar PubMed

11. Modi DN, Sane S, Bhartiya D. Accelerated germ cell apoptosis in sex chromosome aneuploid fetal human gonads. Mol Hum Reprod 2003;9:219–25.10.1093/molehr/gag031Search in Google Scholar PubMed

12. Gupta S, Chiplunkar S, Gupta A, Gollpaudi S. Increased spontaneous, tumor necrosis factor receptor- and CD95 (Fas)-mediated apoptosis in cord blood T-cell subsets from Turner’s syndrome. Genes Immun 2003;4:239–43.10.1038/sj.gene.6363945Search in Google Scholar PubMed

13. Mortensen KH, Andersen NH, Gravholt CJ. Cardiovascular phenotype in Turner syndrome-integrating cardiology, genetics and endocrinology. Endo Rev 2012;33:677–714.10.1210/er.2011-1059Search in Google Scholar PubMed

14. Bondy C, Bakalov VK, Cheng C, Olivieri L, Rosing DR, et al. Bicuspid aortic valve and aortic coarctation are linked to deletion of the X chromosome short arm inTurner syndrome. J Med Genet 2013;50:662–5.10.1136/jmedgenet-2013-101720Search in Google Scholar PubMed PubMed Central

15. Kneppo C, Eichhorn JG, Ley S, Schenk JP, Gorenflo M, et al. Assessment of aortic morphology and compliance in children and adolescents with Ullrich-Turner syndrome (UTS) using magnetic resonance imaging (MRI). J Pediatr Endocrinol Metab 2014;27:915–22.10.1515/jpem-2013-0332Search in Google Scholar PubMed

16. Bonderman D, Gharehbaghi-Schnell E, Wollenek G, Maurer G, Baumgartner H, et al. Mechanisms underlying aortic dilatation in congenital aortic valve malformation. Circulation 1999;99:2138–43.10.1161/01.CIR.99.16.2138Search in Google Scholar

17. Cotrufo M, Della Corte A, De Santo LS, Quarto C, De Feo M, et al. Different patterns of extracellular matrix protein expression in the convexity and the concavity of the dilated aorta with bicuspid aortic valve:preliminary results. J Thorac Cardiovasc Surg 2005;130:504–11.10.1016/j.jtcvs.2005.01.016Search in Google Scholar PubMed

18. Kim J, Park J, Choi S, Chi SG, Mowbray AL, et al. X-linked inhibitor of apoptosis protein is an important regulator of vascular endothelial growth factor-dependent bovine aortic endothelial cell survival. Circ Res 2008;102:896–904.10.1161/CIRCRESAHA.107.163667Search in Google Scholar PubMed PubMed Central

19. Kim J, Ahn S, Ko YG, Boo YC, Chi SG, et al. X-linked inhibitor of apoptosis protein controls alpha5-integrin-mediated cell adhesion and migration. Am J Physiol Heart Circ Physiol 2010;299:H300–9.10.1152/ajpheart.00180.2010Search in Google Scholar PubMed PubMed Central

20. Ahn S, Park H. XIAP is essential for shear stress-enhanced Tyr-576 phosphorylation of FAK. Biochem Biophys Res Commun 2010;399:256–61.10.1016/j.bbrc.2010.07.064Search in Google Scholar PubMed

21. Peng X, Wu X, Druso JE, Wei H, Park AY, et al. Cardiac developmental defects and eccentric right ventricular hypertrophy in cardiomyocyte focal adhesion kinase (FAK) conditional knockout mice. Proc Natl Acad Sci USA 2008;105:6638–43.10.1073/pnas.0802319105Search in Google Scholar PubMed PubMed Central

22. Porteous S, Torban E, Cho NP, Cunliffe H, Chua L, et al. Primary renal hypoplasia in humans and mice with PAX2 mutations:evidence of increased apoptosis in fetal kidneys of Pax2 (1 Neu)+/- mutant mice. Hum Mol Genet 2000;9:1–11.10.1093/hmg/9.1.1Search in Google Scholar PubMed

23. Vischioni B, van der Valk P, Span SW, Kruyt FA, Rodriguez JA, et al. Expression and localization of inhibitor of apoptosis proteins in normal human tissues. Hum Pathol 2006;37:78–86.10.1016/j.humpath.2005.09.022Search in Google Scholar PubMed

24. Yang X, Zhou Y, Peng S, Wu L, Lin HY, et al. Differentially expressed plasma microRNAs in premature ovarian failure patients and the potential regulatory function of mir-23a in granulosa cell apoptosis. Reproduction 2012;144:235–44.10.1530/REP-11-0371Search in Google Scholar PubMed

25. Zinn AR, Tonk VS, Chen Z, Flejter WL, Gardner HA, et al. Evidence for a Turner syndrome locus or loci at Xp11.2-p22.1. Am J Hum Genet 1998;63:1757–66.10.1086/302152Search in Google Scholar PubMed PubMed Central

26. Arroba AI, Lechuga-Sancho AM, Frago LM, Argente J, Chowen JA. Cell-specific expression of X-linked inhibitor of apoptosis in the anterior pituitary of streptozotocin-induced diabetic rats. J Endocrinol 2007;192:215–27.10.1677/joe.1.06985Search in Google Scholar PubMed

Received: 2014-5-20
Accepted: 2014-9-26
Published Online: 2014-11-12
Published in Print: 2015-11-1

©2015 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Highlight: Turner syndrome
  3. Turner syndrome – working together with patients and their families
  4. Turner syndrome patients with bicuspid aortic valves and renal malformations exhibit abnormal expression of X-linked inhibitor of apoptosis protein (XIAP)
  5. Inhibin B in adolescents and young adults with Turner syndrome
  6. Mode of initial presentation and chromosomal abnormalities in Irish patients with Turner syndrome: a single-centre experience
  7. Retrospective evaluation of pubertal development and linear growth of girls with Turner Syndrome treated with oral and transdermal estrogen
  8. Turner syndrome in Albania and the efficacy of its treatment with growth hormone
  9. Review articles
  10. The relation of vitamin D status with metabolic syndrome in childhood and adolescence: an update
  11. Putting the pieces together: cryptorchidism – do we know everything?
  12. Original articles
  13. Investigation of androgen receptor gene mutations in a series of 21 patients with 46,XY disorders of sex development
  14. Molecular diagnosis of maturity-onset diabetes of the young (MODY) in Turkish children by using targeted next-generation sequencing
  15. Association of physical activity level with depression, anxiety, and quality of life in children with type 1 diabetes mellitus
  16. Neonatal diabetes in Ukraine: incidence, genetics, clinical phenotype and treatment
  17. The effect of intraoperative administration of dexamethasone for PONV prophylaxis on perioperative blood glucose level in obese and normal weight children
  18. Are obesity and metabolic syndrome associated with plasma adropin levels in children?
  19. Carnitine insufficiency in children with inborn errors of metabolism: prevalence and treatment efficacy
  20. Comparison of energy expenditure, body composition, metabolic disorders, and energy intake between obese children with a history of craniopharyngioma and children with multifactorial obesity
  21. Effect of serum cholesterol on bone mineral density in normal-weight children and adolescents
  22. Assessment of bone turnover markers and bone mineral density in normal short boys
  23. Long-term treatment for hyperphenylalaninemia and phenylketonuria: a risk for nutritional vitamin B12 deficiency?
  24. Risk factors affecting the development of nephrocalcinosis, the most common complication of hypophosphatemic rickets
  25. Children with hyperthyroidism younger than age 7 require higher mg/kg doses of methimazole to normalize free T4 compared to older children
  26. Effects of bisphosphonates to treat osteoporosis in children with cerebral palsy: a meta-analysis
  27. AMH levels at central precocious puberty and premature thelarche: is it a parameter?
  28. Validating Paediatric Morphometrics: body proportion measurement using photogrammetric anthropometry
  29. Treatment of central precocious puberty and early puberty with GnRH analog in girls with Williams-Beuren syndrome
  30. Short communication
  31. Pilot study on the dietary habits and lifestyles of girls with idiopathic precocious puberty from the city of Rome: potential impact of exposure to flame retardant polybrominated diphenyl ethers
  32. Patient reports
  33. Hypomagnesemia due to two novel TRPM6 mutations
  34. A novel mutation of AMH in three siblings with persistent Mullerian duct syndrome
  35. Kocher-Debré-Semelaigne syndrome with rhabdomyolysis and increased creatinine
  36. Anaphylaxis to gonadorelin acetate in a girl with central precocious puberty
  37. Efficacy and safety of sirolimus in a neonate with persistent hypoglycaemia following near-total pancreatectomy for hyperinsulinaemic hypoglycaemia
https://doi.org/10.1515/jpem-2014-0208
Keywords for this article
apoptosis; bicuspid aortic valves; Turner syndrome; XIAP

Articles in the same Issue

  1. Frontmatter
  2. Highlight: Turner syndrome
  3. Turner syndrome – working together with patients and their families
  4. Turner syndrome patients with bicuspid aortic valves and renal malformations exhibit abnormal expression of X-linked inhibitor of apoptosis protein (XIAP)
  5. Inhibin B in adolescents and young adults with Turner syndrome
  6. Mode of initial presentation and chromosomal abnormalities in Irish patients with Turner syndrome: a single-centre experience
  7. Retrospective evaluation of pubertal development and linear growth of girls with Turner Syndrome treated with oral and transdermal estrogen
  8. Turner syndrome in Albania and the efficacy of its treatment with growth hormone
  9. Review articles
  10. The relation of vitamin D status with metabolic syndrome in childhood and adolescence: an update
  11. Putting the pieces together: cryptorchidism – do we know everything?
  12. Original articles
  13. Investigation of androgen receptor gene mutations in a series of 21 patients with 46,XY disorders of sex development
  14. Molecular diagnosis of maturity-onset diabetes of the young (MODY) in Turkish children by using targeted next-generation sequencing
  15. Association of physical activity level with depression, anxiety, and quality of life in children with type 1 diabetes mellitus
  16. Neonatal diabetes in Ukraine: incidence, genetics, clinical phenotype and treatment
  17. The effect of intraoperative administration of dexamethasone for PONV prophylaxis on perioperative blood glucose level in obese and normal weight children
  18. Are obesity and metabolic syndrome associated with plasma adropin levels in children?
  19. Carnitine insufficiency in children with inborn errors of metabolism: prevalence and treatment efficacy
  20. Comparison of energy expenditure, body composition, metabolic disorders, and energy intake between obese children with a history of craniopharyngioma and children with multifactorial obesity
  21. Effect of serum cholesterol on bone mineral density in normal-weight children and adolescents
  22. Assessment of bone turnover markers and bone mineral density in normal short boys
  23. Long-term treatment for hyperphenylalaninemia and phenylketonuria: a risk for nutritional vitamin B12 deficiency?
  24. Risk factors affecting the development of nephrocalcinosis, the most common complication of hypophosphatemic rickets
  25. Children with hyperthyroidism younger than age 7 require higher mg/kg doses of methimazole to normalize free T4 compared to older children
  26. Effects of bisphosphonates to treat osteoporosis in children with cerebral palsy: a meta-analysis
  27. AMH levels at central precocious puberty and premature thelarche: is it a parameter?
  28. Validating Paediatric Morphometrics: body proportion measurement using photogrammetric anthropometry
  29. Treatment of central precocious puberty and early puberty with GnRH analog in girls with Williams-Beuren syndrome
  30. Short communication
  31. Pilot study on the dietary habits and lifestyles of girls with idiopathic precocious puberty from the city of Rome: potential impact of exposure to flame retardant polybrominated diphenyl ethers
  32. Patient reports
  33. Hypomagnesemia due to two novel TRPM6 mutations
  34. A novel mutation of AMH in three siblings with persistent Mullerian duct syndrome
  35. Kocher-Debré-Semelaigne syndrome with rhabdomyolysis and increased creatinine
  36. Anaphylaxis to gonadorelin acetate in a girl with central precocious puberty
  37. Efficacy and safety of sirolimus in a neonate with persistent hypoglycaemia following near-total pancreatectomy for hyperinsulinaemic hypoglycaemia
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 19.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2014-0208/pdf
Scroll to top button